Treatment of Alopecia Areata: A Journey from Classical Therapeutic Options to New Drugs in Recent Years

    January 2018 in “ Dermatology Online Journal ”
    Alba Gómez‐Zubiaur, David Saceda‐Corralo, MD Velez-Velazquez, Sergio Vañó‐Galván
    Studysummary This review discusses current pharmacological proposals for treating alopecia areata, highlighting the need for individualized treatment plans due to limited clinical trial evidence and potential for spontaneous remission.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on escholarship.org →
    Discuss this study in the Community →

    Research cited in this study 75

    1. Tofacitinib 2% Ointment, a Topical Janus Kinase Inhibitor, for the Treatment of Alopecia Areata: A Pilot Study of 10 Patients Journal of the American Academy of Dermatology · 2017
    2. Lack of Efficacy of Apremilast in 9 Patients with Severe Alopecia Areata Journal of the American Academy of Dermatology · 2017
    3. Alopecia Areata: A Comprehensive Review of Pathogenesis and Management Clinical Reviews in Allergy & Immunology · 2017
    4. Management of Alopecia Areata: Updates and Algorithmic Approach Journal of dermatology · 2017
    5. Topical Janus Kinase Inhibitors for the Treatment of Pediatric Alopecia Areata Journal of the American Academy of Dermatology · 2017
    6. Alopecia Areata: An Update on Treatment Options for Children Paediatric drugs · 2017
    7. Review of Treatment for Alopecia Totalis and Alopecia Universalis International Journal of Dermatology · 2017
    8. Treatment of Alopecia Areata With Tofacitinib JAMA Dermatology · 2017
    9. Two Cases of Alopecia Areata Treated with Ruxolitinib: A Discussion of Ideal Dosing and Laboratory Monitoring International Journal of Dermatology · 2017
    10. Experience with Oral Tofacitinib in 8 Adolescent Patients with Alopecia Universalis Journal of the American Academy of Dermatology · 2017
    11. Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata Pediatric dermatology · 2017
    12. Tofacitinib for the Treatment of Alopecia Areata and Variants in Adolescents Journal of the American Academy of Dermatology · 2016
    13. Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients Journal of The American Academy of Dermatology · 2016
    14. Treating Alopecia Areata: Current Practices Versus New Directions American journal of clinical dermatology · 2016
    15. Efficacy and Safety of Superficial Cryotherapy for Alopecia Areata: A Retrospective Comprehensive Review of 353 Cases Over 22 Years The Journal of Dermatology · 2016
    16. Safety and Efficacy of the JAK Inhibitor Tofacitinib Citrate in Patients with Alopecia Areata JCI insight · 2016
    17. A Novel Therapeutic Paradigm for Patients with Extensive Alopecia Areata Expert Opinion on Biological Therapy · 2016
    18. Pulse Corticosteroid Therapy With Oral Dexamethasone for the Treatment of Adult Alopecia Totalis and Universalis Journal of the American Academy of Dermatology · 2016
    19. A Systematic Review of Pulse Steroid Therapy for Alopecia Areata Journal of the American Academy of Dermatology · 2016
    20. Topical Ruxolitinib for the Treatment of Alopecia Universalis JAMA dermatology · 2015
    21. Extensive Alopecia Areata Is Reversed by IL-12/IL-23p40 Cytokine Antagonism The Journal of Allergy and Clinical Immunology · 2015
    22. Alopecia Areata Profiling Shows TH1, TH2, and IL-23 Cytokine Activation Without Parallel TH17/TH22 Skewing ˆThe ‰journal of allergy and clinical immunology/Journal of allergy and clinical immunology/˜The œjournal of allergy and clinical immunology · 2015
    23. Combined Oral Pulse and Topical Corticosteroid Therapy for Severe Alopecia Areata in Children: A Long-Term Follow-Up Study Dermatologic therapy · 2015
    24. Benefit of Different Concentrations of Intralesional Triamcinolone Acetonide in Alopecia Areata: An Intrasubject Pilot Study Journal of the American Academy of Dermatology · 2015
    25. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib EBioMedicine · 2015
    26. Efficacy and Safety of Diphenylcyclopropenone Alone or in Combination with Anthralin in the Treatment of Chronic Extensive Alopecia Areata: A Retrospective Case Series Journal of the American Academy of Dermatology · 2015
    27. Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata Annals of dermatology/Annals of Dermatology · 2015
    28. Bimatoprost Versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study Dermatology · 2015
    29. Role of Platelet-Rich Plasma in Chronic Alopecia Areata: Our Centre Experience Indian Journal of Plastic Surgery · 2015
    30. The PDE4 Inhibitor, Apremilast, Suppresses Experimentally Induced Alopecia Areata in Human Skin In Vivo Journal of Dermatological Science · 2014
    31. Alopecia Universalis Successfully Treated With Adalimumab JAMA dermatology · 2014
    32. Efficacy and Safety of Methotrexate in Alopecia Areata Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia · 2014
    33. Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition Nature medicine · 2014
    34. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients Journal of the American Academy of Dermatology · 2014
    35. Limited Effectiveness of Platelet-Rich Plasma Treatment on Chronic Severe Alopecia Areata Hair therapy & transplantation · 2014
    36. The Effect of Oral Cyclosporine in the Treatment of Severe Alopecia Areata Cutaneous and ocular toxicology · 2013
    37. A Randomized, Double-Blind, Placebo- and Active-Controlled, Half-Head Study to Evaluate the Effects of Platelet-Rich Plasma on Alopecia Areata British Journal of Dermatology · 2013
    38. The Safety and Efficacy of Diphencyprone for the Treatment of Alopecia Areata in Children Archives of dermatology · 2012
    39. Autologous Platelet-Rich Plasma: A Potential Therapeutic Tool for Promoting Hair Growth Dermatologic Surgery · 2012
    40. A Study to Evaluate the Efficacy of Various Topical Treatment Modalities for Alopecia Areata International journal of trichology · 2012
    41. Efficacy and Tolerability of Methotrexate in Severe Childhood Alopecia Areata British journal of dermatology/British journal of dermatology, Supplement · 2011
    42. Alefacept for Severe Alopecia Areata: A Randomized, Double-Blind, Placebo-Controlled Study Yearbook of Dermatology and Dermatologic Surgery · 2011
    43. Bimatoprost in the Treatment of Eyelash Universalis Alopecia Areata International Journal of Trichology · 2010
    44. Lack of Efficacy of Topical Latanoprost and Bimatoprost Ophthalmic Solutions in Promoting Eyelash Growth in Patients with Alopecia Areata Yearbook of Dermatology and Dermatologic Surgery · 2010
    45. Latanoprost in the Treatment of Eyelash Alopecia in Alopecia Areata Universalis Journal of The European Academy of Dermatology and Venereology · 2009
    46. Phase I/II Randomized Bilateral Half-Head Comparison of Topical Bexarotene 1% Gel for Alopecia Areata Journal of the American Academy of Dermatology · 2009
    47. 308-nm Excimer Laser for the Treatment of Alopecia Areata in Children Pediatric dermatology · 2009
    48. Combination Therapy With Oral PUVA and Corticosteroid for Recalcitrant Alopecia Areata Archives of dermatological research · 2009
    49. Lack of Efficacy of Topical Latanoprost and Bimatoprost Ophthalmic Solutions in Promoting Eyelash Growth in Patients with Alopecia Areata Journal of The American Academy of Dermatology · 2009
    50. Lack of Response of Alopecia Areata to Pimecrolimus Cream Clinical and experimental dermatology · 2007
    51. A Comparison of the Efficacy, Relapse Rate, and Side Effects Among Three Modalities of Systemic Corticosteroid Therapy for Alopecia Areata Yearbook of Dermatology and Dermatologic Surgery · 2007
    52. Efficacy And Safety Of A New Clobetasol Propionate 0.05% Foam In Alopecia Areata: A Randomized, Double-Blind Placebo-Controlled Trial Journal of the European Academy of Dermatology and Venereology · 2006
    53. Twice Weekly 5 mg Betamethasone Oral Pulse Therapy in the Treatment of Alopecia Areata Journal of the European Academy of Dermatology and Venereology · 2006
    54. Determination of the Sildenafil Effect on Alopecia Areata in Childhood: An Open-Pilot Comparison Study Journal of Dermatological Treatment · 2006
    55. A Comparison of the Efficacy, Relapse Rate, and Side Effects Among Three Modalities of Systemic Corticosteroid Therapy for Alopecia Areata Dermatology · 2006
    56. Use of the Pulsed Infrared Diode Laser (904 nm) in the Treatment of Alopecia Areata Journal of cosmetic and laser therapy · 2006
    57. Lack of Efficacy of Topical Latanoprost in the Treatment of Eyebrow Alopecia Areata Journal of The American Academy of Dermatology · 2005
    58. 308-Nm Excimer Laser Therapy in Alopecia Areata Journal of the American Academy of Dermatology · 2004
    59. Autoimmunity: Alopecia Areata Journal of Investigative Dermatology Symposium Proceedings · 2004
    60. Guidelines for the Management of Alopecia Areata British Journal of Dermatology · 2003
    61. Efficacy of Betamethasone Valerate Foam Formulation in Comparison with Betamethasone Dipropionate Lotion in the Treatment of Mild-to-Moderate Alopecia Areata: A Multicenter, Prospective, Randomized, Controlled, Investigator-Blinded Trial International Journal of Dermatology · 2003
    62. Clobetasol Propionate 0.05% Under Occlusion in the Treatment of Alopecia Totalis/Universalis Journal of the American Academy of Dermatology · 2003
    63. Topical Tacrolimus (FK506): Treatment Failure in Four Cases of Alopecia Universalis Acta dermato-venereologica · 2002
    64. Management of Alopecia Areata Clinical and Experimental Dermatology · 2002
    65. Sulfasalazine for Alopecia Areata Journal of the American Academy of Dermatology · 2002
    66. Treatment of Widespread Alopecia Areata in Young Patients with Monthly Oral Corticosteroid Pulse Pediatric Dermatology · 1998
    67. Topical Tretinoin as an Adjunctive Therapy with Intralesional Triamcinolone Acetonide for Alopecia Areata: Clinical Experience in Northern Saudi Arabia International Journal of Dermatology · 1997
    68. Pulsed Administration of Corticosteroids in the Treatment of Alopecia Areata International Journal of Dermatology · 1996
    69. Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata Archives of Dermatology · 1992
    70. Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata Archives of Dermatology · 1992
    71. Treatment-Resistant Alopecia Areata: Response to Combination Therapy with Minoxidil Plus Anthralin Archives of Dermatology · 1990
    72. Evaluation of Anthralin in the Treatment of Alopecia Areata Archives of dermatology · 1987
    73. Topical Minoxidil Solution (1% and 5%) in the Treatment of Alopecia Areata Journal of The American Academy of Dermatology · 1987
    74. Topical Photochemotherapy for Alopecia Areata Journal of the American Academy of Dermatology · 1985
    75. Topical Minoxidil in the Treatment of Alopecia Areata BMJ · 1983